High-level expression and purification of the recombinant diphtheria fusion toxin DTGM for PHASE I clinical trials

Protein Expression and Purification

Volumn 16, Issue 1, 1999, Pages 190-201

  Frankel, Arthur E ^a   Ramage, Jason ^a   Latimer, Amy ^a   Feely, Theodore ^a   Delatte, Stephen ^c   Hall, Philip ^c   Tagge, Edward ^c   Kreitman, Robert ^d   Willingham, Mark ^b  

^a Department of Cancer Biology ^*  (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABACA; AFFINITY CHROMATOGRAPHY; BLOOD CELL; CLINICAL TRIAL; DIPHTHERIA TOXIN; GEL PERMEATION CHROMATOGRAPHY; GENETIC ENGINEERING; HISTOCHEMISTRY; HYBRID PROTEIN; IMMUNOANALYSIS; ION EXCHANGE CHROMATOGRAPHY; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN PURIFICATION; RECOMBINANT PROTEIN;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; LIMULUS; MUSA TEXTILIS;

EID: 0033152021     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1006/prep.1999.1071     Document Type: Article

References (39)

1. Parker, S., Tong, T., Bolden, S., and Wingo, P. (1997) Cancer statistics, 1997. CA J. Clin. 47, 5-27.
2. Bennett, J. M., Young, M. L., Andersen, J. W., Cassileth, P. A., Tallman, M. S., Paietta, E., Wiernik, P. H., and Rowe, J. M. (1997) Long-term survival in acute myeloid leukemia: The Eastern Cooperative Oncology Group experience. Cancer 80(Suppl 11), 2205-2209.
3. Cassileth, P. A., Harrington, D. P., Appelbaum, F. R., Lazarus, H. M., Rowe, J. M., Paietta, E., Willman, C., Hurd, D. D., Bennett, J. M., Blume, K. G., Head, D. R., and Wiernik, P. H. (1998) Chemotherapy compared with autologous or allogeneic bone marrow transplantation in the management of acute myeloid leukemia in first remission. N. Engl. J. Med. 339, 1649-1656.
4. List, A. (1996) Role of multidrug resistance and its pharmacological modulation in acute myeloid leukemia. Leukemia 10, 937-942.
5. Kantarjian, H. M., Estey, E. H., and Keating, M. A. (1996) New chemotherapeutic agents in acute myeloid leukemia. Leukemia 10(Suppl 1), S4-S6.
6. Wong, G. G., Witek, J. S., Temple, P. A., Willars, K. M., Leavy, A. C., Luxenberg, D. P., Jones, S. S., Broom, E. L., Kay, R. M., Orr, E. C., Shoemaker, C., Golde, D. W., Kaufman, R. J., Hewick, R. M., and Clark, S. C. (1985) Human GMCSF molecular cloning of the complementary DNA and purification of the natural and recombinant proteins. Science 228, 810-815.
7. Cannistra, S. A., Groshek, P., Garlick, R., Miller, J., and Griffin, J. D. (1990) Regulation of surface expression of the granulocyte/macrophage colony-stimulating factor in normal human myeloid cells. Proc. Natl. Acad. Sci. USA 87, 93-97.
8. Engert, A., Brown, A., and Thorpe, P. (1991) Resistance of myeloid leukaemia cell lines to ricin A-chain immunotoxins. Leukemia Res. 15, 1079-1086.
9. Choe, S., Bennett, M. J., Fujii, G., Curmi, P. M. G., Kantardjieff, K. A., Collier, R. J., and Eisenberg, D. (1992) The crystal structure of diphtheria toxin. Nature 357, 216-222.
10. Naglich, J., Metherall, J., Russell, D., and Eidels, L. (1992) Expression cloning of a diphtheria toxin receptor: Identity with a heparin-binding EGF-like growth factor precursor. Cell 69, 1051-1061.
11. Gordon, V., Klimpel, K., Arora, N., Henderson, M., and Leppla, S. (1995) Proteolytic activation of bacterial toxins by eukaryotic cells is performed by furin and by additional cellular proteases. Infect Immun. 63, 82-87.
12. Van Ness, B. G., Howard, J. B., and Bodley, J. W. (1980) ADP-ribosylation of elongation factor 2 by diphtheria toxin: Isolation and properties of the novel ribosyl-amino acid and its hydrolysis products. J. Biol. Chem. 255, 10717-10720.
13. Kochi, S. K., and Collier, R. J. (1993) DNA fragmentation and cytolysis in U937 cells treated with diphtheria toxin or other inhibitors of protein synthesis. Exp. Cell Res. 208, 296-302.
14. Murphy, J. R., Bishai, W., Borowski, M., Miyanohara, A., Boyd, J., and Nagle, S. (1986) Genetic construction, expression, and melanoma-selective cytotoxicity of a diphtheria toxin-related alpha-melanocyte-stimulating hormone fusion protein. Proc. Natl. Acad. Sci. USA 83, 8258-8262.
15. Williams, D. P., Parker, K., Bacha, P., Bishai, W., Borowski, M., Genbauffe, F., Strom, T. B., and Murphy, J. R. (1987) Diphtheria toxin receptor binding domain substitution with interleukin-2: Genetic construction and properties of a diphtheria toxin-related interleukin-2 fusion protein. Protein Eng. 1, 493-498.
16. Lakkis, F., Steele, A., Pacheco-Silva, A., Rubin-Kelley, V., Strom, T. B., and Murphy, J. R. (1991) Interleukin 4 receptor targeted cytotoxicity: Genetic construction and in vivo immunosuppressive activity of a diphtheria toxin-related murine interleukin 4 fusion protein. Eur. J. Immunol. 21, 2253-2258.
17. Jean, L. F., and Murphy, J. R. (1991) Diphtheria toxin receptor-binding domain substitution with interleukin 6: Genetic construction and interleukin 6 receptor-specific action of a diphtheria toxin-related interleukin 6 fusion protein. Protein Eng. 4, 989-994.
18. Landgraf, R., Pegram, M., Slamon, D. J., and Eisenberg, D. (1998) Cytotoxicity and specificity of directed toxins composed of diphtheria toxin and the EGF-like domain of heregulin β1. Biochemistry 37, 3220-3228.
19. Hogge, D. F., Willman, C. L., Kreitman, R. J., Berger, M., Hall, P. D., Kopecky, K. J., McLain, C., Tagge, E. P., Eaves, C. J., and Frankel, A. E. (1998) Malignant progenitors from patients with acute myelogenous leukemia are sensitive to a diphtheria toxin-granulocyte-macrophage colony-stimulating factor fusion protein. Blood 92, 589-595.
20. Frankel, A. E., Lilly, M., Kreitman, R. J., Hogge, D., Beran, M., Freedman, M. H., Emanuel, P. D., McLain, C., Hall, P. D., Tagge, E. P., Berger, M., and Eaves, C. (1998) Diphtheria toxin fused to granulocyte-macrophage colony-stimulating factor is toxic to blasts from patients with juvenile myelomonocytic leukemia and chronic myelomonocytic leukemia. Blood 92, 4279-4286.
21. Kreitman, R. J., and Pastan, I. (1997) Recombinant toxins containing human granulocyte-macrophage colony-stimulating factor and either pseudomonas exotoxin or diphtheria toxin kill gastrointestinal cancer and leukemia cells. Blood 90, 252-259.
22. Burbage, C., Tagge, E. P., Harris, B., Hall, P. D., Fu, T., Willingham, M. C., and Frankel, A. E. (1997) Ricin fusion toxin targeted to the human granulocyte-macrophage colony-stimulating factor receptor is selectively toxic to acute myeloid leukemia cells. Leukemia Res. 21, 681-690.
23. Frankel, A. E., Hall, P. D., Burbage, C., Vesely, J., Willingham, M. C., Bhalla, K., and Kreitman, R. J. (1997) Modulation of the apoptotic response of human myeloid leukemia cells to a diphtheria toxin granulocyte-macrophage colony-stimulating factor fusion protein. Blood 90, 3654-3661.
24. Frankel, A. E., Hall, P. D., McLain, C., Safa, A. R., Tagge, E. P., and Kreitman, R. J. (1998) Cell-specific modulation of drug resistance in acute myeloid leukemic blasts by diphtheria fusion toxin, DT388-GMCSF. Bioconjugate Chem. 9, 490-496.
25. Kim, C. N., Bhalla, K., Kreitman, R. J., Willingham, M. C., Hall, P. D., Tagge, E. P., Jia, T., and Frankel, A. E. (1998) Diphtheria Toxin Fused to Granulocyte-macrophage Colony-stimulating FacTor and Ara-C Exert Synergistic Toxicity Against Human AML HL-60 Cells. Submitted for publication.
26. Hall, P. D., Kreitman, R. J., Willingham, M. C., and Frankel, A. E. (1998) Toxicology and pharmacokinetics of DT388-GM-CSF, a fusion toxin consisting of a truncated diphtheria toxin (DT388) linked to human granulocyte-macrophage colony-stimulating factor (GM-CSF) in C57BL/6 mice. Toxicol. Appl. PharMacol. 150, 91-97.
27. Hall, P. D., Willingham, M. C., Kreitman, R. J., and Frankel, A. E. (1999) DT388-GM-CSF, a novel fusion toxin consisting of a truncated diphtheria toxin fused to human granulocyte-macrophage colony-stimulating factor, prolongs host survival in a SCID mouse model of acute myeloid leukemia. Leukemia, in press.
28. Studier, F. W., and Moffatt, B. A. (1986) Use of bacteriophage T7 RNA polymerase to direct selective high-level expression of cloned genes. J. Mol. Biol. 189, 113-130.
29. Hwang, J., FitzGerald, D. J., Adhya, S., and Pastan, I. (1987) Functional domains of Pseudomonas exotoxin identified by deletion analysis of the gene expressed in E. Coli. Cell 48, 129-136.
30. Chaudhary, V. K., FitzGerald, D. J., Adhya, S., and Pastan, I. (1987) Activity of a recombinant fusion protein between transforming growth factor type a and Pseudomonas toxin. Proc. Natl. Acad. Sci. USA 84, 4538-4542.
31. Chaudhary, V. K., FitzGerald, D. J., and Pastan, I. (1991) A proper amino terminus of diphtheria toxin is important for cytotoxicity. Biochem. Biophys. Res. Commun. 180, 545-551.
32. Lorberboum-Galski, H., Garsia, R. J., Gately, M., Brown, P. S., Clark, R. F., Waldmann, T. A., Chaudhary, V. K., FitzGerald, D. J., and Pastan, I. (1990) IL2-PE664Glu, a new chimeric protein cytotoxic to human-activated T lymphocytes. J. Biol. Chem. 265, 16311-16317.
33. Myers, D. E., Irvin, J. D., Smith, R. S., Kuebelbeck, V. M., and Uckun, F. M. (1991) Production of a pokeweed antiviral protein (PAP)-containing immunotoxin, B43-PAP, directed against the CD19 human B lineage lymphoid differentiation antigen in highly purified form for human clinical trials. J. Immunol. MethOds 136, 221-238.
34. Ghetie, V., Thorpe, P., Ghetie, M. A., Knowles, P., Uhr, J. W., and Vitetta, E. S. (1991) The GLP large scale preparation of immunotoxins containing deglycosylated ricin A chain and a hindered disulfide bond. J. Immunol. Methods 142, 223-230.
35. Vallera, D. A., Burns, L. J., Frankel, A. E., Sicheneder, A. R., Gunther, R., Gajl-Peczalska, K., Pennell, C. A., and Kersey, J. H. (1996) Laboratory preparation of a deglycosylated ricin toxin A chain containing immunotoxin directed against a CD7 T lineage differentiation antigen for phase I human clinical studies involving T cell malignancies. J. Immunol. Methods 197, 69-83.
36. Dubendorff, J. W., and Studier, F. W. (1991) Controlling basal expression in an inducible T7 expression system by blocking the target T7 promoter with lac repression. J. Mol. Biol. 219, 45-59.
37. Brinkmann, U., Mattes, R. E., and Buckel, P. (1989) High-level expression of recombinant genes in Escherichia coli is dependent on the availability of the dnaY gene product. Gene 85, 109-114.
38. Buchner, J., Pastan, I., and Brinkmann, U. (1992) A method for increasing the yield of properly folded recombinant fusion proteins: Single-chain immunotoxins from renaturation of bacterial inclusion bodies. Anal. Biochem. 205, 263-270.
39. Rajagopal, V., Pastan, I., and Kreitman, R. J. (1997) A form of anti-Tac(Fv) which is both single-chain and disulfide stabilized: Comparison with its single-chain and disulfide-stabilized homologs. Protein Eng. 10, 1453-1459.